Found: 17
Select item for more details and to access through your institution.
Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.
- Published in:
- EMBO Journal, 2006, v. 25, n. 15, p. 3596, doi. 10.1038/sj.emboj.7601248
- By:
- Publication type:
- Article
Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
- Published in:
- EMBO Journal, 1999, v. 18, n. 5, p. 1378, doi. 10.1093/emboj/18.5.1378
- By:
- Publication type:
- Article
Differential proteolytic activation of the Bacillus thuringiensis Cry41Aa parasporin modulates its anticancer effect.
- Published in:
- Biochemical Journal, 2019, v. 476, n. 24, p. 3805, doi. 10.1042/BCJ20190732
- By:
- Publication type:
- Article
The human cancer cell active toxin Cry41Aa from Bacillus thuringiensis acts like its insecticidal counterparts.
- Published in:
- Biochemical Journal, 2017, v. 474, n. 10, p. 1591, doi. 10.1042/BCJ20170122
- By:
- Publication type:
- Article
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.18270
- By:
- Publication type:
- Article
Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.
- Published in:
- Nucleic Acids Research, 2018, v. 46, n. 7, p. 3707, doi. 10.1093/nar/gky038
- By:
- Publication type:
- Article
RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.
- Published in:
- Nucleic Acids Research, 2016, v. 44, n. 10, p. 4636, doi. 10.1093/nar/gkw085
- By:
- Publication type:
- Article
Disruption of CTCF-YY1–dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription.
- Published in:
- PLoS Biology, 2018, v. 16, n. 10, p. 1, doi. 10.1371/journal.pbio.2005752
- By:
- Publication type:
- Article
Upregulation of the Cell-Cycle Regulator RGC-32 in Epstein-Barr Virus-Immortalized Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028638
- By:
- Publication type:
- Article
A Shared Receptor Suggests a Common Ancestry between an Insecticidal Bacillus thuringiensis Cry Protein and an Anti-Cancer Parasporin.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 795, doi. 10.3390/biom14070795
- By:
- Publication type:
- Article
Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 7, p. 1, doi. 10.1371/journal.ppat.1007458
- By:
- Publication type:
- Article
Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway.
- Published in:
- Oncogene, 1998, v. 17, n. 6, p. 769, doi. 10.1038/sj.onc.1201990
- By:
- Publication type:
- Article
Regulation of B cell receptor signalling by Epstein–Barr virus nuclear antigens.
- Published in:
- Biochemical Journal, 2022, v. 479, n. 23, p. 2395, doi. 10.1042/BCJ20220417
- By:
- Publication type:
- Article
Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline.
- Published in:
- Toxins, 2022, v. 14, n. 5, p. 319, doi. 10.3390/toxins14050319
- By:
- Publication type:
- Article
Modulation of Enhancer Looping and Differential Gene Targeting by Epstein-Barr Virus Transcription Factors Directs Cellular Reprogramming.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 9, p. 1, doi. 10.1371/journal.ppat.1003636
- By:
- Publication type:
- Article
RNA Polymerase II Stalling Promotes Nucleosome Occlusion and pTEFb Recruitment to Drive Immortalization by Epstein-Barr Virus.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 10, p. 1, doi. 10.1371/journal.ppat.1002334
- By:
- Publication type:
- Article
Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4‐MYC oncogenic axis in multiple myeloma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 3, p. 417, doi. 10.1002/hon.3016
- By:
- Publication type:
- Article